Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Clinical trial NCT06467084 · COMPLETED

Trial details

NCT number: NCT06467084
Sponsor: KalVista Pharmaceuticals, Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2024-08-01
Primary completion: 2026-01-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.